On-Demand CME Videos
Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Stop the Itch that Rashes: Online CME Activity
This activity was recorded at the 2022 Fall Clinical Dermatology Conference on October 22, 2022.
CME Satellite Symposium: Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Stop the Itch that Rashes
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
November 15, 2022
November 15, 2024
At the completion of this activity, participants should be better able to:
Overview the key data on systemic biologics for the management of moderate-to-severe atopic dermatitis in children and adolescents
Identify children and adolescents who would benefit from biologics for the management of moderate-to-severe atopic dermatitis
Describe strategies to integrate biologics into daily clinical practice to effectively manage moderate-to-severe AD
Benjamin Lockshin, MD
EVP of Strategic Initiatives
Director of the Clinical Trials Center
US Dermatology Partners
Mona Shahriari, MD
Central CT Dermatology
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Abbvie, Eli Lilly, Celgene, Regeneron, Sanofi Genzyme, DermTech, Exact Sciences, Pfizer, Leo, Arcutis, Dermavant
Consultant: AbbVie, Eli Lilly, Regeneron, Sanofi Genzyme, DermTech, Exact Sciences, Dermavant, Arcutis, Leo
Speakers’ Bureau or Honoraria: Abbvie, Eli Lilly, Regeneron, Sanofi Genzyme, Dermavant, Arcutis, Leo
Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union
Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB
Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.